1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Biopeutics Co., Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure Alprostadil - End Stage Cardiac Failure, HFrEF - Heart Failure With Reduced Ejection Fraction | Phase 3 | Not yet recruiting | Biopeutics Co., Ltd | 600 | 2026-10-01 | 2025-12-15 |
Alprostadil (1)
Austria (1)
Martin Huelsmann, MD (1) · Noemi Pavo, MD PhD (1)